Addex Therapeutics Ltd (ADXN) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
02M5M8M10M12M15M18M20MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
02K5K8K10K12K15K18K20KQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Operating Expenses

Research And Development ExpensesGeneral And Administrative ExpensesOther Expenses
0250K500K750K1M1M2M2M2MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

EBITDA

EBITDA
-3M-3M-2M-2M-1M-1M-750K-375K1Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

EPS

EPSEPS Diluted
0612192531384450Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Revenue Variation (%)

Revenue Variation
-2005751K2K3K4K4K5K6KQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0918263544526170Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Revenue YoY Variation (%)

Revenue YoY Variation
-200-175-150-125-100-74-49-241Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Income YoY Variation (%)

Price-to-Earning Ratio

P/E Ratio
-2-2-1-1-0-0011Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Income Breakdown

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
02M5M8M10M12M15M18M20MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000001111Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To Revenue
0918263544526170Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Free Cash Flow

Cash Flow to Debt Ratio

Cash At End Of Period
0750K2M2M3M4M4M5M6MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025
🏦 Balance Sheet
📈 Key Metrics